Modified oligonucleotides

dc.assigneeNovartis AG
dc.contributor.authorDe Mesmaeker, Alain
dc.contributor.authorWendeborn, Sebastian
dc.contributor.authorLebreton, Jaques
dc.date.accessioned2024-08-16T11:38:20Z
dc.date.available2024-08-16T11:38:20Z
dc.date.issued1998-01-08
dc.description.abstractIt is one object of the present invention to provide an oligonucleotide of formula (1): 5'-(U)n-3' in which U is an identical or different radical of a natural or a synthetic nucleoside, wherein the oligonucleotide comprises at least one modified nucleotide dimer comprising two nucleoside analogs connected via an amide-bond that has a certain configuration; the synthesis of these compounds and their use in pharmaceutical preparations.
dc.identifier.patentWO9800434
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/46946
dc.identifier.urihttps://doi.org/10.26041/fhnw-9970
dc.publisherWorld Intellectual Property Organization
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subject.ddc500 - Naturwissenschaften und Mathematik
dc.titleModified oligonucleotides
dc.type12 - Patent
dspace.entity.typePublication
fhnw.InventedHereNo
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Chemie und Bioanalytikde_CH
relation.isAuthorOfPublication931d1ba8-5284-4fea-9c44-3ebcc003d638
relation.isAuthorOfPublication.latestForDiscovery931d1ba8-5284-4fea-9c44-3ebcc003d638
Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild
Name:
WO9800434A1_Original_document_20240806114709.pdf
Größe:
4.02 MB
Format:
Adobe Portable Document Format

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Kein Vorschaubild vorhanden
Name:
license.txt
Größe:
2.66 KB
Format:
Item-specific license agreed upon to submission
Beschreibung: